Online Registration is now closed, however if you would like to attend please email aline@onenucleus.com

In this new VIC workshop we’ll cover the fundamentals of drug development programmes, the main considerations and their evolution as biotechs mature their pre clinical data. It is specifically dedicated to early stage companies who need to show their understanding of the underlying principles of drug development to their stakeholders and ensure they know how to evolve them as the company progresses. 

Programme:

11.30 - Welcome and introduction

11.35 - Presentation on key considerations to prepare for:

- Investors at the various inflection points

• Mapping expected ROI for the Target Product Profile
• Costing the development plan

- Regulatory Authorities and work-up to a pre-IND meeting, including  Investiga

• Investigator Brochure
• Outline development plans
• POC indication vs TPP indication

12.10 - Q&A

12.30 - End 

This event is free to attend and open to all.